2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
FDA Comment Number : EC91
Submitter : Mr. Marlin Anderson Date & Time: 12/07/2005 06:12:00
Organization : Mr. Marlin Anderson
Category : Individual Consumer
Issue Areas/Comments
GENERAL
GENERAL
Direct to Consumer Advertising of antidepressants and other psychiatric drugs should simply not be allowed at all. This advertising promotes unproven theories such as that there is a chemical imbalance in the brain, and often allows individuals to complete a 'self-diagnosis' questionnaire on-line. For example, see the Paxil.com website. After completing the questionnaire, individuals are encouraged to use a particular psychiatric drug. These same individuals will then ask their general practitioner physician if he or she will prescribe this drug, and the pharmaceuctical companies get sales that they otherwise might not have obtained if they had relied solely on physician advertising. Direct to Consumer Advertising of antidepressants and other psychiatric drugs should be banned altogether, and the pharmaceuctical companies should be required to promote their products only to the physicians who are formally trained in such matters.